Oceania Healthcare Ltd (NZSE:OCA)

NZ$ 0.55 0 (0%) Market Cap: 398.32 Mil Enterprise Value: 1.04 Bil PE Ratio: 12.50 PB Ratio: 0.39 GF Score: 50/100

Half Year 2024 Oceania Healthcare Ltd Earnings Call Transcript
Nov 21, 2023

NZ$0.71

Earnings
Oceania Healthcare Ltd Annual Shareholders Meeting Transcript
Aug 25, 2023
Full Year 2023 Oceania Healthcare Ltd Earnings Call Transcript
May 23, 2023

NZ$0.79 (+3.95%)

Earnings
Half Year 2023 Oceania Healthcare Ltd Earnings Call Transcript
Nov 22, 2022

NZ$0.82 (+1.23%)

Earnings
Oceania Healthcare Ltd Annual Shareholders Meeting Transcript
Jun 23, 2022
Full Year 2022 Oceania Healthcare Ltd Earnings Call Transcript
May 20, 2022

NZ$1.04 (+0.97%)

Earnings
Half Year 2022 Oceania Healthcare Ltd Earnings Call Transcript
Nov 28, 2021

Earnings
Oceania Healthcare Ltd Annual Shareholders Meeting Transcript
Jun 24, 2021
Full Year 2021 Oceania Healthcare Ltd Earnings Call Transcript
May 21, 2021

NZ$1.33 (-1.48%)

Earnings
Half Year 2021 Oceania Healthcare Ltd Earnings Call Transcript
Jan 21, 2021

NZ$1.5 (+0.67%)

Earnings
Oceania Healthcare Ltd Annual Shareholders Meeting Transcript
Sep 24, 2020
Full Year 2020 Oceania Healthcare Ltd Earnings Call Transcript
Jul 22, 2020

NZ$1.03 (+0.98%)

Earnings
Half Year 2020 Oceania Healthcare Ltd Earnings Call Transcript
Jan 23, 2020

NZ$1.31

Earnings
Oceania Healthcare Ltd Annual Shareholders Meeting Transcript
Aug 29, 2019
Full Year 2019 Oceania Healthcare Ltd Earnings Call Transcript
Jul 24, 2019

NZ$1.07 (+0.94%)

Earnings

Full Year 2019 Oceania Healthcare Ltd Earnings Call Transcript

Jul 24, 2019 / 10:30PM GMT

Release Date Price: NZ$1.07 (+0.94%)

Transcript

Operator

Good day, ladies and gentlemen, and welcome to the Oceania Healthcare Limited Annual Results Conference Call. Just a reminder that today's program is being recorded.

At this time, I would like to hand things over to Mr. Earl Gasparich. Please go ahead, sir.

Earl Gasparich

Oceania Healthcare Limited - CEO

Well, good morning, everyone, and thank you for coming on to the call this morning. My name is Earl Gasparich, as you've just heard. And with me today is Matt Ward, CFO. We're pleased to bring you this presentation of our annual results for the year ended 31 May 2019, which were announced this morning.

So I'll run you through the highlights of the 2019 financial year before giving an update on progress and executing our strategy at Oceania Healthcare. And I'll then run through our key development projects, both those recently completed and currently underway, before handing over to Matt to present the financial results in more detail.

But first, before we get into the highlights of the year, I wanted to use the strategy on our page

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.